Pancreatic Cancer Research

ResearcherUniversity of CambridgeActive in the last 2 years

Gary Abel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2231-5161; OpenAlex author ID A5029437177. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. Risk factors for pancreatic cancer in electronic health records: an umbrella review of systematic reviews and meta-analyses. Last author DOI 10.1016/j.eclinm.2025.103297↗
  2. Clinical risk factors for pancreatic cancer: protocol for an umbrella review. Last author DOI 10.1136/bmjopen-2024-089008↗
  3. Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study. Co-author DOI 10.1016/s2468-1253(16)30079-6↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fiona Mary Walter · 3 shared papers, 2016–2025 · strength 0.60
  2. Sarah F. Moore · 2 shared papers, 2024–2025 · strength 0.54
  3. Katie Mills · 1 shared paper, 2016 · strength 0.05
  4. William Trevor Hamilton · 1 shared paper, 2016 · strength 0.05
  5. Jon D. Emery · 1 shared paper, 2016 · strength 0.05
  6. Bristi Basu · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.